Home | Welcome to Contract Pharma   
Last Updated Sunday, November 23 2014
Print RSS Feed

Harlan CRS, Bertin Pharma Enter Strategic Pact



By Kristin Brooks



Published March 4, 2014
Harlan Contract Research Services and Bertin Pharma, headquartered in Montigny-le-Bretonneux, France, have entered a strategic partnership to offer comprehensive services for early drug development. The companies will offer a wider range of drug discovery and translational medicine services, including expanded profiling and molecule testing, particularly in the context of regulatory studies. Harlan CRS will provide its drug discovery and translational medicine offerings using Bertin Pharma’s expertise in immunology and biomarkers.
 
“The new agreement benefits us both strategically and scientifically,” said Ciriaco Maraschiello, director of strategic initiatives and director of drug discovery and translational medicine at Harlan CRS. “Working together, we will provide the pharmaceutical industry the best team of scientists to increase the likelihood of success for new generation drugs.”
 
“For Bertin Pharma, this partnership will increase our international visibility and allow us to expand our services by integrating project management capabilities and expertise,” said Xavier Morge, managing director of Bertin Pharma.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On